ETV Bharat / advertorial

Remedium Lifecare Receives ₹8,500 Crore Mega Order, Achieving a New Milestone in Indian Pharma

Mumbai: Taking a significant step in the Indian pharmaceutical industry, Remedium Lifecare Limited

Image
Image (Remedium Lifecare)
author img

By ETV Bharat English Team

Published : Jan 7, 2025, 5:08 PM IST

Mumbai: Taking a significant step in the Indian pharmaceutical industry, Remedium Lifecare Limited has received a massive ₹8,500 crore order from the world’s largest pharmaceutical company, Eli Lilly & Company. This special achievement is not only enhancing the company’s global identity but also proving to be a milestone for the Indian pharma sector. This news has created a buzz in the market, as there is speculation about a significant surge in the company’s stock prices following this order.

Remedium Lifecare specializes in the trading and sales of active pharmaceutical ingredients (APIs) and intermediates. The receipt of this large order from Lilly will strengthen the company’s market position and could result in a major change in its financial performance. Analysts also believe that this order could open several new doors for the company’s future.

Stable Financial Structure and Promoter Confidence

The company’s current PE ratio stands at 11, while the sector’s PE ratio is 60. This indicates that the company has a stable financial structure, which protects it from market pressures. Another important point is that Remedium Lifecare is a zero-debt company, which helps it remain stable over the long term. Promoters hold a stable 65% stake in the company, reflecting trust in its future and the strength of its financial management.

Company History and Global Presence

Established in 1988, Remedium Lifecare started its journey by supplying pharmaceutical intermediates domestically. Over time, the company expanded its presence in international markets and is now actively involved in trading pharmaceutical APIs and intermediates. In the last three years, the company has achieved a compound sales growth rate of 255%, further strengthening its growth trajectory.

Impact on the Global Pharma Sector

The ₹8,500 crore order from Eli Lilly & Company will help Remedium Lifecare secure a prominent position in the global pharma industry. This move is also significant for making Indian pharma companies more competitive on the international stage. Experts believe that Remedium Lifecare could achieve even greater accomplishments on the global platform in the future.

Mumbai: Taking a significant step in the Indian pharmaceutical industry, Remedium Lifecare Limited has received a massive ₹8,500 crore order from the world’s largest pharmaceutical company, Eli Lilly & Company. This special achievement is not only enhancing the company’s global identity but also proving to be a milestone for the Indian pharma sector. This news has created a buzz in the market, as there is speculation about a significant surge in the company’s stock prices following this order.

Remedium Lifecare specializes in the trading and sales of active pharmaceutical ingredients (APIs) and intermediates. The receipt of this large order from Lilly will strengthen the company’s market position and could result in a major change in its financial performance. Analysts also believe that this order could open several new doors for the company’s future.

Stable Financial Structure and Promoter Confidence

The company’s current PE ratio stands at 11, while the sector’s PE ratio is 60. This indicates that the company has a stable financial structure, which protects it from market pressures. Another important point is that Remedium Lifecare is a zero-debt company, which helps it remain stable over the long term. Promoters hold a stable 65% stake in the company, reflecting trust in its future and the strength of its financial management.

Company History and Global Presence

Established in 1988, Remedium Lifecare started its journey by supplying pharmaceutical intermediates domestically. Over time, the company expanded its presence in international markets and is now actively involved in trading pharmaceutical APIs and intermediates. In the last three years, the company has achieved a compound sales growth rate of 255%, further strengthening its growth trajectory.

Impact on the Global Pharma Sector

The ₹8,500 crore order from Eli Lilly & Company will help Remedium Lifecare secure a prominent position in the global pharma industry. This move is also significant for making Indian pharma companies more competitive on the international stage. Experts believe that Remedium Lifecare could achieve even greater accomplishments on the global platform in the future.

ETV Bharat Logo

Copyright © 2025 Ushodaya Enterprises Pvt. Ltd., All Rights Reserved.